abstract |
The present invention relates to the use of a proprotein convertase subtilisin/kexin type 9 or PCSK9 inhibitor for the prevention and/or treatment of metastasis in a subject who is suffering from cancer and is undergoing, or is going to undergo, mechanical ventilation. |